PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

levomilnacipran vs venlafaxine

Side-by-side comparison of levomilnacipran and venlafaxine Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
levomilnacipran Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
venlafaxine Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
Type
levomilnacipran Prescription
venlafaxine Prescription
Summary
levomilnacipran

Fetzima is a medicine used to treat major depressive disorder (MDD) in adults. It helps to improve your mood by affecting certain chemicals in the brain.

venlafaxine

Venlafaxine is a medication used to treat depression. It helps to improve your mood by affecting certain chemicals in the brain.

What It Treats
levomilnacipran

Fetzima is used to treat major depressive disorder (MDD) in adults. MDD can cause you to feel sad, lose interest in activities, and have trouble with daily life. Fetzima can help improve your mood and reduce these symptoms.

venlafaxine

Venlafaxine is used to treat major depressive disorder. This condition can cause a persistent feeling of sadness or loss of interest in daily activities. It may also help maintain improvement in patients with recurrent depression.

How It Works
levomilnacipran

Fetzima is a type of drug called a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of serotonin and norepinephrine in your brain. These chemicals can help improve your mood and reduce symptoms of depression.

venlafaxine

Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of serotonin and norepinephrine in the brain. These chemicals help regulate mood and can be low in people with depression.

Common Side Effects
levomilnacipran
  • Nausea
  • Constipation
  • Increased sweating
  • Increased heart rate
  • Erectile dysfunction
venlafaxine
  • Feeling weak or tired
  • Sweating a lot
  • Feeling sick to your stomach
  • Constipation
  • Loss of appetite
FAERS Reports
levomilnacipran
  • Using the medicine for something it's not approved for 327
  • The medicine is not working 246
  • Pain 210
  • Throwing up 208
  • Trouble remembering things 189
venlafaxine
  • The medicine is not working 5,510
  • Feeling sick to your stomach 4,298
  • Harmful effects from different substances 4,264
  • Feeling tired 4,199
  • Using the medicine for a purpose it's not approved for 4,123
Serious Warnings
levomilnacipran

Antidepressants may increase the risk of suicidal thoughts and behaviors in young adults. Your doctor should closely watch you for worsening depression or suicidal thoughts. Fetzima is not approved for use in children.

venlafaxine

Antidepressants may increase the risk of suicidal thoughts and behaviors in children, adolescents, and young adults. Your doctor will monitor you closely for worsening depression, suicidal thoughts, or unusual changes in behavior. Venlafaxine is not approved for use in children.

Pregnancy
levomilnacipran

Tell your doctor if you are pregnant or plan to become pregnant. Using Fetzima in the last months of pregnancy may cause problems in the newborn. There is a pregnancy registry for women who take antidepressants during pregnancy.

venlafaxine

If you are pregnant or breastfeeding, talk to your doctor before taking venlafaxine. Newborns exposed to SNRIs like venlafaxine in the third trimester may have complications requiring hospitalization. Your doctor will carefully consider the risks and benefits of treatment during pregnancy.

Also Compare — Nearby Drugs

How to Read This levomilnacipran vs venlafaxine Comparison

levomilnacipran is classified in the Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) drug class, while venlafaxine sits within the Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) class. Because both drugs share the same classification, they are often considered interchangeable in theory — but clinical outcomes rarely track that cleanly. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, levomilnacipran has 1,180 submissions while venlafaxine has 22,394. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between levomilnacipran and venlafaxine — always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.